CARTITUDE-1 Update
CARTITUDE-1 Update: Phase I/II Trial of Ciltacabtagene Autoleucel for Heavily Pretreated Relapsed/Refractory Multiple Myeloma

Released: June 09, 2023

Activity

Progress
1
Course Completed